Next 10 |
home / stock / tlt / tlt articles
Lauren Goodwin, economist and Chief Market Strategist at New York Life Investments, has suggested that equity markets may continue to perform until...
Mohamed El-Erian, the chief economic advisor at Allianz, took to X, formerly Twitter, to highlight a significant economic indicator that points to ...
To gain an edge, this is what you need to know today. Hell To Pay Please click here for an enlarged chart of iShares 20+ Year Treasury Bond ETF (N...
To gain an edge, this is what you need to know today. Extraordinary Move In Treasuries Please click here for an enlarged chart of 20+ year Treasur...
Investors in the iShares 20+ Year Treasury Bond ETF (NASDAQ:TLT) are grappling with unexpected challenges as inflation heats up, sending shockwaves...
In March, the U.S. labor market surged beyond predictions, with 303,000 nonfarm payrolls added, surpassing expectations of 212,000. This marked the...
Every cycle brings new opportunities; now that the Federal Reserve (the Fed) is looking to cut interest rates in 2024, the market could be getting ...
The bond market is showing new signs of unpredictability as expectations over Fed rate cuts shift with every new piece of economic data. Last week,...
The number of U.S. citizens filing new claims for unemployment benefits fell more sharply than expected last week, underpinning the Federal Reserve...
News, Short Squeeze, Breakout and More Instantly...
iShares 20+ Year Treasury Bond ETF Company Name:
TLT Stock Symbol:
NASDAQ Market:
TORONTO, ON / ACCESSWIRE / June 20, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their formu...
TORONTO, ON / ACCESSWIRE / June 19, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their formu...
TORONTO, ON / ACCESSWIRE / April 14, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their form...